Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 61,100
+600 (0.99%)
Nov 20, 2025, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.63 trillion as of November 20, 2025. Its market cap has increased by 0.35% in one year.
Market Cap
2.63T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
101.68
Stock Price
61,100.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.63T, an increase of 3,864.73%. That is a compound annual growth rate of 20.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 2.63T | 6.69% |
| Dec 30, 2024 | 2.47T | -35.41% |
| Dec 28, 2023 | 3.82T | 44.48% |
| Dec 29, 2022 | 2.64T | -43.45% |
| Dec 30, 2021 | 4.67T | -46.31% |
| Dec 30, 2020 | 8.71T | 511.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.78T |
| ALTEOGEN | 29.09T |
| SK Biopharmaceuticals | 9.84T |
| ABL Bio | 9.37T |
| Yuhan | 8.68T |
| Peptron | 7.80T |
| LigaChem Biosciences | 6.31T |